Overview A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus Status: Not yet recruiting Trial end date: 2024-01-04 Target enrollment: Participant gender: Summary The aim of this trial is to evaluate the efficacy and safety of HRS-7535 in subjects with type 2 diabetes mellitus. Phase: Phase 2 Details Lead Sponsor: Shandong Suncadia Medicine Co., Ltd.